Act Now: BBWI Investors Face Final Deadline for Class Action!

All of Bath & Body Works’ debt is fixed-rate, insulating it from rising interest rates on existing notes (www.sec.gov). The debt carries fairly high coupons – ranging from ~5.25% up to 9.375% on that 2025 note (www.sec.gov) – reflecting the company’s below-investment-grade credit status. Credit rating agencies Moody’s and S&P rate BBWI at Ba2/BB with a stable outlook, i.e. non-investment grade (“junk”) but in the upper tier of speculative-grade corporates (www.sec.gov). This rating acknowledges Bath & Body Works’ substantial debt and only moderate growth, balanced by its strong cash flows and brand. The company’s net leverage stands around 2.8× EBITDA (on a “lease-adjusted” basis, as the company calculates) after the 2023 debt reduction (www.sec.gov). This is an improvement from ~3.1× a year prior, but still higher than most investment-grade retailers. Management has signaled an intent to further deleverage – for example, by retiring debt early (the company realized $34 million in pre-tax gains in 2023 from buying back bonds below par) (investors.bbwinc.com). If BBWI can continue generating surplus cash, it may pay down or refinance the 2025 and 2027 notes, which would incrementally lower interest costs going forward.

Coverage and Cash Flow

Despite its debt load, Bath & Body Works has ample interest coverage and healthy cash flow generation at present. In 2023, the company’s operating income was $1.285 billion (investors.bbwinc.com) and cash interest paid was about $346 million (www.sec.gov). This implies an EBIT/interest coverage ratio of roughly 3.7×, or closer to 4.5× if using EBITDA. In other words, BBWI’s earnings can cover its interest obligations several times over – a comfortable margin, although lower than highly rated peers. The company’s fixed-charge coverage (considering operating leases as well) is slightly tighter, but still solid, aided by the fact that many Bath & Body Works stores are in favorable lease locations (often short inline leases in malls or strip centers). The debt service burden is significant – interest expense was around 7% of sales in 2023 – so any steep decline in profits could stress coverage. However, BBWI’s consistent cash flow has enabled it to invest, pay dividends, and reduce debt simultaneously in recent years.

Notably, Bath & Body Works produced $954 million in operating cash flow in 2023 (www.sec.gov) and about $668 million in free cash flow after $286 million in capital expenditures (www.sec.gov). This level of cash generation easily covered the year’s $182+ million in dividends and ~$148 million in open-market share repurchases (www.sec.gov) (www.sec.gov). It also allowed the company to extinguish debt (over $447 million in debt repayments in 2023) without compromising liquidity (www.sec.gov) (www.sec.gov). Such strong free cash flow – driven by BBWI’s high merchandise margins and relatively low maintenance capex needs – is a key strength underpinning its financial profile. It provides flexibility for the company to “self-fund” obligations due in the next couple of years (like the 2025 note) if credit markets are unfavorable, and to continue shareholder returns. That said, management must balance these uses of cash: during 2022, an aggressive $1 billion accelerated share repurchase (ASR) was executed (www.sec.gov) (www.sec.gov), which reduced share count but also drew down cash reserves. Going forward, investors will want to see that capital allocation (dividends, buybacks, debt paydown) remains prudent relative to earnings trends.

Valuation and Comparative Metrics

BBWI stock currently appears undervalued by traditional metrics, though this likely reflects investor concern over its growth prospects. The shares trade around the mid-$20s (approximately $24 as of mid-February 2026), down from the low-$30s before the late-2025 guidance cut. At this price, Bath & Body Works’ price-to-earnings ratio is only about 6×–8×. On a trailing 12-month basis, the P/E is roughly 6 (using FY2023 actual EPS of $3.84), and on a forward basis (using management’s reset FY2025 EPS guidance of ≥$2.83 (www.nasdaq.com)) the stock is about 8.5× earnings. This is a steep discount to the broader market and to many retail peers. For context, mall-based retailers like Macy’s and The Gap trade at ~12×–13× earnings, and specialty apparel names like American Eagle around 23× (ycharts.com). Even Victoria’s Secret (BBWI’s former sister company) has a P/E in the teens (companiesmarketcap.com). Bath & Body Works’ EV/EBITDA also signals a low valuation – the company’s enterprise value (~$8.2 billion, including debt) is about 5.3× its ~$1.55 billion adjusted EBITDA, which is on the low end for a stable, cash-generative retail business.

This discounted valuation suggests that investors are skeptical about BBWI’s growth trajectory and perhaps pricing in further earnings risk. Bath & Body Works was historically viewed as a solid mid-growth retailer – prior to 2022, it often traded at a low double-digit P/E. The compression to single-digit multiples came as sales growth stalled and management’s expansion bets stumbled (more on risks below). If the company can regain a mid-single-digit growth rate and rebuild investor confidence, there is room for multiple expansion. For instance, at 12× forward earnings (still below the market average), the stock would trade closer to $35 based on ~$2.90–$3.00 in forward EPS – significantly above current levels. Of course, achieving that depends on delivering results. Investors considering BBWI today are effectively betting that its core franchise – selling soaps, lotions, and candles – will continue throwing off reliable profits, and that management will avoid value-destroying experiments. The low valuation provides a margin of safety, but it’s also reflective of the real challenges and uncertainties the business faces.

From a shareholder yield perspective, BBWI has been quite shareholder-friendly: the combination of its ~3–4% dividend yield and share buybacks (which averaged a high single-digit percentage of market cap in 2022–2023 due to the large ASR) means the company returned a substantial yield of capital to equity holders. However, those buybacks were done at much higher stock prices (e.g. ~$49/share in the ASR) (www.sec.gov), so the efficacy of that capital deployment is debatable. Going forward, if the stock remains depressed and the business stabilizes, buybacks at these levels could be accretive. In terms of other valuation metrics, BBWI’s price-to-sales is around 0.6× (with ~$7.3B revenue), and its dividend payout ratio is ~25% of earnings – both undemanding. The main overhang is not the current valuation, but whether earnings will erode further or not. Thus, the stock’s upside could be unlocked if Bath & Body Works proves it can stop the earnings decline and resume modest growth – a big “if” that leads us into the risks and open questions.

Risks and Red Flags

Stagnant Growth and Strategy Missteps: A key risk is slow growth in BBWI’s core business and the failure of expansion initiatives. Bath & Body Works’ sales have essentially flatlined (fiscal 2023 sales were down ~1.7% to $7.43B (investors.bbwinc.com)), and attempts to expand into new product categories did not yield the hoped-for growth. The company’s own filings acknowledge that it operates in a “highly competitive” retail environment where consumer trends change rapidly, and that success depends on continually developing new merchandise and product lines (www.sec.gov). The recent adjacency strategy was a case in point: management invested in men’s grooming, hair care, and other categories, but ultimately admitted these moves “had not grown our total customer base” and began exiting underperforming lines (www.newyorkdailyledger.com). The class action allegations – that the company overstated the success of these initiatives (www.newyorkdailyledger.com) – highlight a red flag in strategic execution and perhaps transparency. If Bath & Body Works cannot find new avenues of growth (whether new categories, digital channels, or international markets) and must rely only on its maturing core lines, revenue could stagnate or decline over time. Competition also looms: while BBWI is a leader in its niche, rivals range from specialty brands (e.g. The Body Shop, Lush) to big players like Ulta and countless indie brands online. Consumers’ interest can shift to new fragrance trends or wellness products, so BBWI must continuously refresh its offerings to stay relevant.

Leadership and Governance Concerns: Investor confidence in Bath & Body Works’ leadership has been tested. The company underwent a CEO transition in late 2022 and brought in Gina Boswell to drive a “new chapter,” but the road has been bumpy. Notably, activist investor Third Point took a ~6% stake and publicly criticized BBWI’s board in 2023 for governance and oversight failures (quoteddata.com). In a February 2023 letter, Third Point pointed to “numerous issues” in the board’s oversight of executive pay, succession planning, capital allocation, and overall strategy (quoteddata.com). They argued that board “stumbles” led to a year of stagnation that the new CEO had to contend with (quoteddata.com), and pushed for adding a shareholder representative to the board. While Bath & Body Works did cooperate to appoint an independent director favored by Third Point (Lucy Brady) (quoteddata.com), the activist pressure underscores governance red flags. The fact that management’s optimistic messaging on “strategy is working” (regarding adjacencies) proved overly rosy (www.newyorkdailyledger.com) may further erode trust. Going forward, any signs of poor communication, lack of transparency, or discord between the board and large shareholders could weigh on the stock. Investors will be watching how Boswell and the refreshed board deliver on promises and whether they adjust strategy nimbly post-adjacency flop. Leadership turnover (C-suite or board) is another risk; BBWI’s filings warn that losing key executives or failing to “attract and retain” talent could hurt performance (www.sec.gov) (www.sec.gov).

Macroeconomic and Consumer Spending Risks: As a retailer of discretionary products, Bath & Body Works is vulnerable to consumer spending cycles and macroeconomic pressures. Its merchandise – lotions, candles, soaps – are affordable indulgences, but still non-essentials. High inflation or a weaker economy can slow customer traffic and average ticket size. In late 2023, management noted “ongoing macroeconomic pressures affecting consumers” (investors.bbwinc.com), and a potential recession or prolonged inflation could further dampen demand. Additionally, shifts in consumer behavior (e.g. more shopping online versus in malls) pose a risk. BBWI has been growing its e-commerce channel, but in-store sales at over 1,800 North American locations still drive the bulk of revenue (investors.bbwinc.com). Traffic declines in malls or changes in mall traffic patterns (many BBWI stores are in shopping malls or centers) could impact sales. On the cost side, volatility in raw materials and supply chain is a risk: the company’s products use commodities like fragrances, oils, and packaging. Supply disruptions or higher input costs can squeeze margins. BBWI’s U.S.-centered supply chain was beneficial in the past (especially during COVID disruptions), but it doesn’t make the company immune to broader logistics issues or rising labor costs. Any significant margin pressures (from wages, materials, or promotions needed to drive sales) could hurt earnings given BBWI’s fixed costs (including hefty rent obligations – over $1.1B in lease liabilities) (www.sec.gov).

Leverage and Financial Risk: While Bath & Body Works’ debt is under control for now, its leveraged balance sheet remains a concern. Total adjusted debt (including lease commitments) is about $5.6 billion (www.sec.gov), which amplifies the impact of any earnings downturn. If EBITDA were to decline substantially, BBWI’s leverage ratio would rise and its credit ratings could come under pressure. A downgrade (further into “junk”) could increase borrowing costs or limit access to financing (www.sec.gov). Additionally, about $600 million of debt comes due in 2025–2026 (www.sec.gov) (www.sec.gov) – while the company can likely handle this with cash on hand and ongoing cash flow, any unexpected cash burn (e.g. from a severe drop in sales or a large legal settlement) might complicate plans. So far, Bath & Body Works has managed to service and even pre-pay debt (interest coverage ~4×, and they’ve avoided covenant issues), but investors should monitor interest coverage and liquidity buffers going forward. Another related risk is the opportunity cost of debt: the ~$340+ million in annual interest expense (www.sec.gov) is money not reinvested in the business. If sales soften, the company might face tough choices between funding growth initiatives versus maintaining dividends and buybacks – heightened debt makes those choices more binding. Lastly, rising interest rates in the economy mean any future debt refinancing (bonds due 2028 onward) could come at rates equal or higher than the already high coupons BBWI pays. In short, leverage adds a layer of financial risk that could exacerbate other problems if the business hits a rough patch.

Legal and Reputational Risks: The ongoing class action lawsuit is itself a risk factor. While such securities suits often get settled by companies’ D&O insurers, the allegations of misleading statements are serious. If the lawsuit progresses, it could result in legal costs or a settlement that modestly ding earnings (though likely not material relative to BBWI’s size). More importantly, the suit brings reputational risk – highlighting possible management credibility issues. Bath & Body Works must now operate under the shadow of this litigation, at least in the near term. That might make management more cautious in its public projections (to avoid further liability), potentially leading to conservative guidance. There’s also a chance (albeit low) of regulatory attention if any wrongdoing is substantiated. Apart from the class action, routine legal risks like product liability (for cosmetics or fragranced products), data breaches (they hold customer data through their loyalty program), or compliance with consumer product regulations exist, as with any retailer. Any negative headlines in these areas could tarnish BBWI’s trusted-brand image. Similarly, ESG issues could emerge as red flags – for instance, if consumers become more sensitive to ingredients (chemicals in fragrances) or animal testing (if any, for ingredients) or environmental waste from product packaging, Bath & Body Works would need to respond or face backlash. These aren’t immediate crises, but they are evolving areas of risk in the personal care industry.

Open Questions for Investors

– Can the core business rekindle growth? Now that management is refocusing on Bath & Body Works’ core product lines (hand soaps, body care, and home fragrance), a big question is whether these legacy categories can deliver consistent growth in a mature U.S. market. The company has a loyal following and a highly successful product pipeline of new scents, but reaching new customers or increasing purchase frequency may be challenging without the boost of new categories. Investors will be watching same-store sales trends and customer traffic closely: will BBWI’s merchandising and marketing be enough to drive organic growth in the low-to-mid single digits, or will sales remain flat? The loyalty program, which has enrolled over 33 million members as of 2023 (www.globenewswire.com), is one lever that could help drive repeat purchases – but its impact on revenue growth remains to be seen.

– What is management’s long-term growth strategy? After the failure of the “adjacency” expansion plan, management needs to articulate a credible growth strategy. Will the focus shift to international expansion? Currently Bath & Body Works has over 1,840 stores in North America but only ~450 franchised international locations (investors.bbwinc.com) – a relatively untapped opportunity if executed well. Similarly, can the company grow its digital/e-commerce sales meaningfully without cannibalizing stores? Another avenue might be product innovation within core categories (for example, expanding into natural/clean ingredients, or new formats of home fragrance). CEO Gina Boswell and her team have spoken of a “Consumer First” formula and investing in the brand (www.cosmeticsbusiness.com), but concrete targets (e.g. new store formats, new markets, or partnerships) are not yet clear to investors. With the class action casting doubt on the prior strategic communication, it’s crucial that BBWI’s leadership outline a convincing roadmap for sustainable growth – and then execute on it.

– How will margins and financial policies evolve? Bath & Body Works has maintained healthy margins (in Q3 2023, merchandise margin actually improved despite sales declines (investors.bbwinc.com) (investors.bbwinc.com)), but there are open questions on margin trajectory. Will cost-saving initiatives and supply chain efficiencies offset inflation and any need for heavier promotions? Moreover, as the company laps its major cost-cutting program, can it hold SG&A and operating margins steady? Another question mark is capital allocation: with debt now reduced to a more manageable level, will BBWI continue paying down debt aggressively, or pivot back to more aggressive share buybacks? The board did authorize a new $500 million repurchase in 2024 (www.sec.gov) – will they deploy it at current prices? Additionally, will the $0.20 dividend be raised, or is it effectively frozen given recent earnings pressure? Clarity on these financial policies will shape the stock’s appeal to different investor types (income-oriented vs. growth-oriented).

– What could change the narrative? Lastly, investors should consider what potential catalysts or pitfalls lie ahead. On the upside, a few strong earnings quarters (especially holiday-season results beating expectations) could restore confidence and lift the stock’s multiple from its depressed level. A strategic action like monetizing a brand asset or a joint-venture in international markets could also unlock value. It’s worth noting that Bath & Body Works’ brand equity remains very high – it’s an “iconic” retailer in its space with decades of customer goodwill. That intangible value could attract interest from strategic acquirers or private equity if the public market continues to undervalue the stock. On the downside, if sales continue to erode or next holiday season disappoints, BBWI might be forced to cut costs further or even trim the dividend, which would likely hurt the stock. The outcome of the class action suit is another variable – a protracted legal battle or any damaging revelations could be an overhang. In sum, Bath & Body Works faces a critical period where it must prove that its core franchise can still flourish on its own. Investors should stay alert to quarterly performance and any management updates, as these will help answer whether BBWI is a value trap or a value opportunity in the wake of recent troubles.

Sources:

1. Bath & Body Works Class Action press release (GlobeNewswire) – Bleichmar Fonti & Auld LLP (www.globenewswire.com) (www.newyorkdailyledger.com) (www.newyorkdailyledger.com) (www.newyorkdailyledger.com) 2. Bath & Body Works SEC 10-K FY2023 (filed Mar 2024) – Annual Report (www.sec.gov) (www.sec.gov) (www.sec.gov) (www.sec.gov) (www.sec.gov) (www.sec.gov) (www.sec.gov) (www.sec.gov) (www.sec.gov) 3. Bath & Body Works Q4 2023 Earnings Release (Feb 29, 2024) – Investor Relations (investors.bbwinc.com) (investors.bbwinc.com) (investors.bbwinc.com) 4. Bath & Body Works Q3 2023 Earnings Release (Nov 16, 2023) – Investor Relations (investors.bbwinc.com) (investors.bbwinc.com) 5. Bath & Body Works Dividend History – Company Investor Relations (investors.bbwinc.com) (investors.bbwinc.com) and Macrotrends (www.macrotrends.net) 6. Peer Retailer Valuations – YCharts / industry data (ycharts.com) 7. Third Point Activist Letter to BBWI (Feb 2023) – Third Point LLC (quoteddata.com) (quoteddata.com) 8. News coverage of BBWI outlook cut – Nasdaq/RTT News (www.nasdaq.com) (www.nasdaq.com) and Cosmetics Business (www.cosmeticsbusiness.com) (www.cosmeticsbusiness.com) 9. Bath & Body Works Press Releases – Investor Relations (capital allocation and strategy) (www.sec.gov) (www.globenewswire.com) 10. Bath & Body Works Risk Factors – 2023 10-K (competition, etc.) (www.sec.gov) (www.sec.gov) and AP News (market context) (investors.bbwinc.com).

For informational purposes only; not investment advice.